Loading clinical trials...
Loading clinical trials...
A Phase IV Open-label Study of Predictive Markers in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children Treated With SAIZEN®
Conditions
Interventions
Saizen
Saizen
Locations
13
Argentina
Local Medical Information Office
Buenos Aires, Argentina
Local Medical Information Office
Sydney, Australia
Local Medical Information Office
Vienna, Austria
Local Medical Information Office
Mississauga, Canada
Local Medical InformationOffice
Paris, France
Local Medical Information Office
Munich, Germany
Start Date
May 31, 2005
Primary Completion Date
September 30, 2007
Completion Date
September 30, 2007
Last Updated
June 26, 2018
NCT02417740
NCT07333521
NCT00227253
NCT06780514
NCT04463316
NCT06109935
Lead Sponsor
Merck KGaA, Darmstadt, Germany
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions